QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy business unit. The unit's first achievement is the opening of a new Leukopak collection ...

To continue supporting its customers in their journey through therapeutic development to commercialization, in 2022 MaxCyte moved to its present headquarters, a 67,000 square-foot facility located in ...

BioSpace takes a look at the headlines across a heavy earnings week for biotechs, checking in on Allogene, Rapport and more.

5.2 The impugned goods are for testing of food and not for diagnostic purposes of human beings (including animals). Main ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

The tools Glaze and Nightshade are giving artists hope that they can fight back against AI that hoovers internet data to ...

There might have been almost 10 years between Dragon Age: The Veilguard and its predecessor, but that certainly doesn't mean ...

2024 and supporting multiple investigator-initiated proof-of-concept studies ("IIT") of crofelemer for the rare and orphan disease indications of microvillus inclusion disease (MVID) and short bowel ...

Q3 2024 Earnings Conference Call November 12, 2024 4:45 PM ETCompany ParticipantsJames Hart - Investor RelationsPeter Anevski ...

We’re pleased to present the 2024 Top 50 State Lobbyists. Featured Article: Championing Inclusivity: Expanding Pathways to ...

We demonstrated the use of the recently awarded Nobel Prize concept to build up new light-emitting enzymes, which serve as optical-based probes for biological studies," Yeh said. Better imaging probes ...

‘De Toutes Beautés’ exhibition in Paris, France, aims to tell the story of beauty through art, exploring more than 10,000 ...